Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel target identified for long QT

Feb. 23, 2022

Sorrento's STI-9167 shows neutralizing activity against SARS-CoV-2 Omicron variants

Feb. 23, 2022

Cantargia reports non-GLP toxicology and pharmacokinetic data on CAN-10

Feb. 23, 2022

JBC-1847 proven effective against Staphylococcus aureus infection

Feb. 23, 2022

ALPHA-1062 shown to be neuroprotective in rodent model of traumatic brain injury

Feb. 23, 2022

Actinium and AVEO collaborate to develop novel Ac-225 ErbB3-targeted radiotherapy

Feb. 23, 2022

Phio's INTASYL-based antiviral compounds against SARS-CoV-2 enter in vivo testing

Feb. 23, 2022

Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases

Feb. 23, 2022

Code Bio and Takeda collaborate on gene therapies for rare diseases

Feb. 23, 2022

Microlyse targets VWF and clears microvascular thrombosis

Feb. 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...